|
1
|
Pisani P, Bray F and Parkin DM: Estimates
of the world-wide prevalence of cancer for 25 sites in the adult
population. Int J Cancer. 97:72–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sørlie T, Perou CM, Tibshirani R, et al:
Gene expression patterns of breast carcinomas distinguish tumor
subclasses with clinical implications. Proc Natl Acad Sci USA.
98:10869–10874. 2001.PubMed/NCBI
|
|
3
|
Gast MC, Schellens JH and Beijnen JH:
Clinical proteomics in breast cancer: a review. Breast Cancer Res
Treat. 116:17–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bozzo C, Spolaore B, Toniolo L, et al:
Nerve influence on myosin light chain phosphorylation in slow and
fast skeletal muscles. FEBS J. 272:5771–5785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shevchenko A, Tomas H, Havlis J, Olsen JV
and Mann M: In-gel digestion for mass spectrometric
characterization of proteins and proteomes. Nat Protoc.
1:2856–2860. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Galvão ER, Martins LM, Ibiapina JO,
Andrade HM and Monte SJ: Breast cancer proteomics: a review for
clinicians. J Cancer Res Clin Oncol. 137:915–925. 2011.
|
|
7
|
Acunzo J, Katsogiannou M and Rocchi P:
Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and
HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol.
44:1622–1631. 2012.
|
|
8
|
Keeling J and McKee GT: Heat shock protein
(HSP)27: a further refinement in the diagnosis of suspicious fine
needle aspirates of breast. Cytopathology. 10:40–49. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Y and Li Z: Roles of heat shock
protein gp96 in the ER quality control: redundant or unique
function? Mol Cells. 20:173–182. 2005.PubMed/NCBI
|
|
10
|
Randazzo M, Terness P, Opelz G and Kleist
C: Active-specific immunotherapy of human cancers with the heat
shock protein Gp96-revisited. Int J Cancer. 130:2219–2231. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brackley KI and Grantham J: Activities of
the chaperonin containing TCP-1 (CCT): implications for cell cycle
progression and cytoskeletal organisation. Cell Stress Chaperones.
14:23–31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambrosino C, Tarallo R, Bamundo A, et al:
Identification of a hormone-regulated dynamic nuclear actin network
associated with estrogen receptor alpha in human breast cancer cell
nuclei. Mol Cell Proteomics. 9:1352–1367. 2010. View Article : Google Scholar
|
|
13
|
Vainberg IE, Lewis SA, Rommelaere H, et
al: Prefoldin, a chaperone that delivers unfolded proteins to
cytosolic chaperonin. Cell. 93:863–873. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Razandi M, Pedram A and Levin ER: Heat
shock protein 27 is required for sex steroid receptor trafficking
to and functioning at the plasma membrane. Mol Cell Biol.
30:3249–3261. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang P, Enomoto A and Takahashi M: Cell
biology of the movement of breast cancer cells: intracellular
signalling and the actin cytoskeleton. Cancer Lett. 284:122–130.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Le Naour F, Misek DE, Krause MC, Deneux L,
Giordano TJ, Scholl S and Hanash SM: Proteomics-based
identification of RS/DJ-1 as a novel circulating tumor antigen in
breast cancer. Clin Cancer Res. 7:3328–3335. 2001.PubMed/NCBI
|
|
17
|
Tamesa MS, Kuramitsu Y, Fujimoto M, et al:
Detection of autoantibodies against cyclophilin A and
triosephosphate isomerase in sera from breast cancer patients by
proteomic analysis. Electrophoresis. 30:2168–2181. 2009. View Article : Google Scholar
|
|
18
|
Shukla S, Pranay A, D'Cruz AK, Chaturvedi
P, Kane SV and Zingde SM: Immunoproteomics reveals that cancer of
the tongue and the gingivobuccal complex exhibit differential
autoantibody response. Cancer Biomark. 5:127–135. 2009.
|
|
19
|
Zhang XZ, Xiao ZF, Li C, et al:
Triosephosphate isomerase and peroxiredoxin 6, two novel serum
markers for human lung squamous cell carcinoma. Cancer Sci.
100:2396–2401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu XM, Wang P and Zhu BT: Characterization
of the estradiol-binding site structure of human protein disulfide
isomerase (PDI). PLoS One. 6:e271852011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hashida T, Kotake Y and Ohta S: Protein
disulfide isomerase knockdown-induced cell death is
cell-line-dependent and involves apoptosis in MCF7 cells. J Toxicol
Sci. 1:1–7. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boiteux G, Lascombe I, Roche E,
Plissonnier ML, Clairotte A, Bittard H and Fauconnet S: A-FABP, a
candidate progression marker of human transitional cell carcinoma
of the bladder, is differentially regulated by PPAR in urothelial
cancer cells. Int J Cancer. 124:1820–1828. 2009. View Article : Google Scholar
|
|
23
|
Schachtrup C, Emmler T, Bleck B, Sandqvist
A and Spener F: Functional analysis of
peroxisome-proliferator-responsive element motifs in genes of fatty
acid-binding proteins. Biochem J. 382:239–245. 2004. View Article : Google Scholar
|
|
24
|
Hancke K, Grubeck D, Hauser N, Kreienberg
R and Weiss JM: Adipocyte fatty acid-binding protein as a novel
prognostic factor in obese breast cancer patients. Breast Cancer
Res Treat. 119:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li H, Lu Q, Dong LH, Xue H, Zhou HY and
Yang HJ: Expression of fatty acid binding protein in human breast
cancer tissues. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 23:312–316.
2007.PubMed/NCBI
|
|
26
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I The value of histological
grade in breast cancer: experience from a large study with
long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar
|
